Menu Consumer Healthcare Our world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements. Our portfolio of loved and trusted brands includes Sensodyne, parodontax, Polident, Advil, Voltaren, Panadol, Otrivin, Theraflu and Centrum. We are one of the world’s leading over-the-counter (OTC) healthcare companies with number one positions in a number of markets, including the US, India and Germany. The business generated sales of £10 billion in 2020. Find out more Our marketplace Our strategy Research for product innovation Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition. We focus on delivering innovations that matter to our consumers. We’ve delivered more than 250 new innovative products in the last five years, including the fast-acting, sensitivity pain relief of Sensodyne Rapid Relief, and brought Voltaren Arthritis Gel from the pharmacy to retail in the US through our best-in-class prescription to OTC “switch” capability. You can find out more about our R&D work on Consumer Healthcare products in our Research and Development section. If you have a product idea and believe we might like to partner with you, please submit your idea using our Consumer Healthcare External Online Submission Form. Other business areas Pharmaceuticals Our Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation and oncology. Vaccines We are the world’s largest vaccines company by revenue, delivering vaccines that help protect people at all stages of life. RSS Other GSK websites Market website selector GSKPro for healthcare professionals GSK Study Register Quick links COVID-19 response Behind the science About us Products Careers Investors Media Research and development Responsibility Accessibility/legal Accessibility Terms of use Cookie policy Privacy notice Modern Slavery Act statement 2020 PDF - 191.4KB Sitemap Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business This is our global website, intended for visitors seeking information on GSK’s worldwide business. Our market sites can be reached by visiting our market selector. © 2001-2021 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. We use cookies GSK values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content.Cookie Policy Show detail ❮ OPT OUT ACCEPT ALL